Clinical Trial Update: Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients [Phase 3]

View source ↗

Summary

A Phase 3 study comparing low-dose continuous cyclophosphamide to standard doxorubicin in elderly patients with advanced soft tissue sarcoma was terminated, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Soft Tissue Sarcoma Adult | Phase 3 | Status: TERMINATED